CN106754435A - The construction method of the restructuring mould of citric acid output increased and application - Google Patents

The construction method of the restructuring mould of citric acid output increased and application Download PDF

Info

Publication number
CN106754435A
CN106754435A CN201611236665.8A CN201611236665A CN106754435A CN 106754435 A CN106754435 A CN 106754435A CN 201611236665 A CN201611236665 A CN 201611236665A CN 106754435 A CN106754435 A CN 106754435A
Authority
CN
China
Prior art keywords
hgt1
citric acid
mould
protein
restructuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201611236665.8A
Other languages
Chinese (zh)
Other versions
CN106754435B (en
Inventor
刘龙
殷娴
陈坚
堵国成
李江华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201611236665.8A priority Critical patent/CN106754435B/en
Publication of CN106754435A publication Critical patent/CN106754435A/en
Application granted granted Critical
Publication of CN106754435B publication Critical patent/CN106754435B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/38Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Aspergillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/44Polycarboxylic acids
    • C12P7/48Tricarboxylic acids, e.g. citric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a kind of construction method of the restructuring mould of citric acid output increased, comprise the following steps:HGT1 protein expression frames are built, HGT1 protein expressions inframe includes constitutive promoter and the constitutive promoter HGT1 protein coding genes for connecting and the terminator being connected with HGT1 protein coding genes;Tolerant gene expression frame is built, tolerant gene expression inframe includes constitutive promoter and the constitutive promoter hph genes for connecting and the terminator being connected with hph genes;HGT1 protein expressions frame and tolerant gene expression frame are transformed into mould, obtain recombinating mould.The HGT1 protein expressions frame built present invention simultaneously provides a kind of use above method and restructuring mould.The present invention discloses application of the restructuring mould in fermentation production of citric acid that a kind of use above method builds.The present invention is expressed by starting high-affinity GLUT, and then improves the yield of citric acid in mould, and fermentation time is greatly shortened.

Description

The construction method of the restructuring mould of citric acid output increased and application
Technical field
The present invention relates to technical field of bioengineering, more particularly to a kind of restructuring mould of citric acid output increased structure Method and application.
Background technology
Aspergillus niger is important industrial production bacterium, and carrying out Metabolically engineered research to aspergillus niger at present concentrates on central metabolites The transformation of path and respiratory chain, including glycolytic pathway, TCA circulation, the single-gene expression of the key enzyme of rTCA circulations and gene Coordinate expression, and alternative oxidase overexpression and knockout, but these influences to lemon acid yield of transformation are little, above-mentioned Only enhancing rTCA circulations approach promotes the raising of lemon acid yield in method.
In citric acid industry production, raw material is starch, and starch is filtered by after amylase liquefaction, is obtained clear liquid and is mixed Liquid, by clear liquid and mixed liquid blend and obtains seed and fermentation medium, and now the carbon source of about half is grape in culture medium Sugar, second half carbon source exists in the form of polyglucose.To be many and industrial production bacterium synthesizes a large amount of carbohydrase at the fermentation initial stage Polydextrose is decomposed into glucose, therefore, carbon source is basic in earlier fermentation culture medium exists in the form of glucose, so lemon Absorption of the lemon acid fermentation to carbon source actually refers to the absorption to glucose.
Torres determines aspergillus niger and absorbs glucose in the presence of 2 Km values, respectively 260 μM and 3.67mM, illustrates exist Two sets of movement systems of high-affinity and low-affinity, and the generation as needed for the movement system of low-affinity provides citric acid fermentation Xie Liu, but the movement system is only in concentration of glucose>50g·L-1When work.Because the transhipment of glucose is citric acid fermentation First step, the movement system has in directly influence, therefore adjustment citric acid fermentation production process on citric acid fermentation Glucose transport systems, it is possible to strengthen the yield of citric acid.
The content of the invention
In order to solve the above technical problems, a kind of structure of the restructuring mould it is an object of the invention to provide citric acid output increased Construction method and application, by starting the expression of high-affinity GLUT, with the suction of strengthen glucose phase after fermentation Receive, and then improve the fermentation yield of citric acid in mould.
To achieve the above object, present invention employs following technical scheme:
On the one hand, it is the invention provides a kind of construction method for recombinating mould of citric acid output increased including following Step:
(1) HGT1 protein expression frames are built, HGT1 protein expressions frame connects comprising constitutive promoter and constitutive promoter The HGT1 protein coding genes for connecing and the terminator being connected with HGT1 protein coding genes;
(2) tolerant gene expression frame is built, tolerant gene expression frame connects comprising constitutive promoter and constitutive promoter The hph genes for connecing and the terminator being connected with hph genes;
(3) the tolerant gene expression frame that step (1) HGT1 protein expressions frame and step (2) are obtained is transformed into mould, Obtain recombinating mould.
Further, in step (1), HGT1 protein coding genes derive from aspergillus niger.
Further, in step (1), the nucleotide sequence of HGT1 protein coding genes is as shown in SEQ ID NO.1.
Further, HGT1 protein coding genes have the function of transhipment glucose, and the amino acid sequence of its coding can be sent out Give birth to substitution, missing or the insertion of one or more amino acid.
Preferably, the amino acid sequence of HGT1 protein coding genes coding is as shown in SEQ ID NO.2.
Further, in step (1) neutralization procedure (2), constitutive promoter be PgpdA promoters, gpdA promoters, Pmbf promoters or Pgla promoters.
Further, the sequence of PgpdA promoters is as shown in SEQ ID NO.3.
Further, in step (1) and step (2), terminator is trp terminators.
Further, the sequence of trp terminators is as shown in SEQ ID NO.4.
Further, in step (2), the sequence of hph genes is as shown in SEQ ID NO.5.
Further, in step (2), hygromycin gene expression cassette is built, is easy to the screening of positive clone molecule.It is anti- Property gene expression frame with pAN7-1 as template clone obtain.
Further, in step (3), mould is aspergillus niger, aspergillus oryzae or aspergillus nidulans.
Preferably, in step (3), mould be aspergillus niger Aspergillus niger H915-1, aspergillus oryzae 100-8 or Aspergillus nidulans FGSC A4.
Further, the construction method of HGT1 protein expressions frame, comprises the following steps:
(1) after by terminator sequence digestion, it is connected on pUC19 plasmids, obtains pUC-trp carriers;
(2) after by constitutive promoter sequence PgpdA digestions, it is connected on pUC-trp carriers, obtains pUC-PgpdA- Trp carriers;Constitutive promoter sequence PgpdA may be replaced by gpdA promoters, Pmbf promoters or Pgla promoters;
(3) after by HGT1 sequence double digestions, fragment is connected on pUC-PgpdA-trp carriers, obtains pUC-PgpdA- HGT1-trp expression cassettes.
Further, method for transformation is comprised the following steps:
(1) HGT1 protein expressions frame and tolerant gene expression frame are transferred in mould protoplast through PEG mediated methods;
(2) culture obtains positive colony on the hypertonic soft agar PDA plate of hygromycin resistance, then will be through culture 4-7 days Positive colony be transferred on the flat board containing 150-180mg/L hygromycin further culture and obtain positive colony, checking is correct As recombinate mould.
Due to mould, the phase absorbs glucose by expressing high-affinity GLUT after fermentation, based on this Research foundation, the present invention realizes expression of the high-affinity GLUT HGT1 in different moulds, to strengthen grape The absorption of sugared phase after fermentation.
On the other hand, opened the invention provides a kind of HGT1 protein expressions frame, including constitutive promoter and composing type The HGT1 protein coding genes of mover connection and the terminator being connected with HGT1 protein coding genes.
Further, constitutive promoter is PgpdA promoters, gpdA promoters, Pmbf promoters or Pgla promoters.
Further, HGT1 protein coding genes derive from aspergillus niger, and the nucleotide sequence of HGT1 protein coding genes is such as Shown in SEQ ID NO.1.
Further, terminator is trp terminators.
It yet still another aspect, present invention also offers a kind of restructuring trichoderma strain built by the above method.
Present invention also offers application of the restructuring mould constructed by the above method in fermentation production of citric acid.
Further, the condition of restructuring mold fermentation production citric acid of the invention is:Fermented at a temperature of 30-35 DEG C 72-120h, preferably rotating speed are 250r/min or so.
By such scheme, the present invention at least has advantages below:
The present invention starts HGT1 albumen and is expressed in mould using constitutive promoter, by strengthening fermentation later stage glucose Intake, so as to improve the yield of citric acid;The inventive method has general applicability to the Aspergillus niger strain for producing citric acid, can Fermentation of Aspergillus niger is set to produce citric acid output increased nearly 10%, by the use of Aspergillus niger H915-1 as host, lemon Lemon acid yield improves 14.7%, and fermentation period shortens 6h.
Brief description of the drawings
Fig. 1 is the content measuring result of citric acid and glucose in Aspergillus niger strain;
When Fig. 2 is fermenting and producing, citric acid than rate of producing acid test result.
Specific embodiment
With reference to the accompanying drawings and examples, specific embodiment of the invention is described in further detail.Hereinafter implement Example is not limited to the scope of the present invention for illustrating the present invention.
The extraction of the aspergillus niger RNA of embodiment 1
Aspergillus niger spore is inoculated into citric acid fermentation culture medium, 250r/min cultures 48h, uses at 35 DEG C Mirocloth filter clothes collect bacterium ball, then with aseptic milli-Q water 3 times, are filtered dry and rapid after moisture are freezed in liquid nitrogen.Use liquid nitrogen The method of grinding will be organized and fully ground, and aspergillus niger is extracted using QIAGEN companies RNeasy Plant Mini Kit kits Total serum IgE.With TAKARA companies PrimeScript RT reagent Kit with gDNA Eraser by RNA reverse transcriptions into cDNA。
The extraction of the aspergillus niger genomic DNA of embodiment 2
Aspergillus niger spore is inoculated into ME fluid nutrient mediums (3% malt extract, 0.5% tryptone), at 35 DEG C 250r/min cultivates 48h, and bacterium ball is collected with mirocloth filter clothes, then with aseptic milli-Q water 3 times, is filtered dry rapid after moisture Freezed in liquid nitrogen.To be organized with the method for liquid nitrogen grinding and fully ground, using QIAGEN companies DNeasy Plant Mini Kit extracts filamentous fungi genome.
The structure of the HGT1 protein expressions frame of embodiment 3 and hygromycin resistance expression cassette
Using primer trp-F (sequence is as shown in SEQ ID NO.6) and trp-R (sequence is as shown in SEQ ID NO.7) with PAN7-1 is template amplification trp terminators, and sequence upstream and downstream I containing Pst and Hin dIII restriction enzyme sites are connected on pMD19 and survey Sequence, then uses the two digestion with restriction enzyme, and the sequence is connected on the pUC19 of same digestion, obtains pUC19- trp。
Using primer Pgpd-F (sequence is as shown in SEQ ID NO.8) and Pgpd-R (sequence is as shown in SEQ ID NO.9) PgpdA promoters, sequence two RI containing Eco and Kpn I restriction enzyme sites are expanded from pAN7-1, after digestion, by sequence connection To the pUC19-trp of same digestion, pUC-PgpdA-trp is obtained.
Using primer HGT1-F (sequence is as shown in SEQ ID NO.10) and HGT1-R (sequence such as SEQ ID NO.11 institutes Show) HGT1 genes, gene two I containing Kpn and Pst I restriction enzyme sites are expanded in the aspergillus niger cDNA that is obtained from embodiment 1, It is connected on the pUC-PgpdA-trp of same digestion, forms PgpdA-HGT1-trp expression cassettes.
Hygromycin resistance expression cassette passes through primer gpd-F (sequence is as shown in SEQ ID NO.12) and Ttrp-R-2 (sequences As shown in SEQ ID NO.13) expanded from plasmid pAN7-1 and obtain.
In the present embodiment, amplification condition is as follows:94 DEG C of predegeneration 3min, then carry out 30 circulations, 94 DEG C of 20s, 55 DEG C 20s and 72 DEG C of 3min, last 72 DEG C of reactions 10min.
In the present embodiment, digestion condition is as follows:37 DEG C of digestions 2 hours.
The preparation and conversion of the aspergillus niger protoplast of embodiment 4
By 3 × 105Aspergillus niger spore is seeded to PDA liquid medium by the concentration of/ml, the 200r/min cultures at 30 DEG C Overnight.Bacterium ball is collected with mirocloth filter clothes, and with sterile water wash bacterium ball.A certain amount of lyases is weighed, and uses osmotic pressure Stabilizer KMC dissolves, and uses sterilised membrane filter filtration sterilization.
Weigh a certain amount of bacterium ball, be added in enzymolysis liquid, 37 DEG C, 100r/min concussion and cultivates about 3h until mycelia disappear completely Turn to protoplast, 4 DEG C, 1000rpm centrifugation 10min abandon supernatant, add the STC of same volume precooling, 4 DEG C, 1000rpm from Heart 10min, abandons supernatant, washs 2 times, adds 100 μ L STC, mixes.
To adding 10 μ L linearized nucleic acids fragment (HGT1 protein expressions frame and hygromycin in 100 μ L aspergillus niger protoplasts Resistance expression's frame) and 330 μ L PEG buffer solutions, 20min is placed on ice, 2mL PEG are added, room temperature is placed 10min, is sequentially added 4mL STC and 4mL is plated on the lower floor's culture medium containing 180mg/L hygromycin in 48 DEG C of upper strata culture mediums of preheating.Flat board Culture 4-7 days is inverted at 35 DEG C, until there is bacterium colony, picking single bacterium colony subculture.Each bacterium colony carries out 3 monospore subcultures.
The aspergillus niger of embodiment 5 converts the checking of suboutput
Aspergillus niger is inoculated in PDA culture medium, raw spore culture 5-7 days, scrape spore, with 10 at 35 DEG C6The inoculation of/mL Amount is inoculated in seed culture medium, 37 DEG C, 250r/min culture 24h, with 1/10 inoculum concentration switching fermentation medium, 35 DEG C, 250r/ Min fermentations 72h.Zymotic fluid centrifugation removal thalline, dilutes 10 times, and citric acid content is detected with HPLC methods with after membrane filtration, HPLC method testing conditions are as follows:
Instrument:The high performance liquid chromatographs of Agilent 1200 (match somebody with somebody UV-vis detector, Composition distribution and work station); Chromatographic condition:HPX87H chromatographic columns (4.6 × 250mm, 5 μm), mobile phase is 5mM sulfuric acid solutions, and flow is 0.6mL/min, is entered Sample amount is 10 μ L, and column temperature is 30 DEG C, the detection of 210nm length ultraviolets light.
Fig. 1 is reflected in different strains, and the content results of citric acid and glucose, wherein H915-1 represent wild black song Trichoderma strain, HGT1 represents recombinant bacterial strain of the invention, it can be seen that the citric acid of recombinant aspergillus niger bacterial strain of the invention Yield is improved, and its yield improves 14.6% or so, and fermentation later stage than wild-type strain, and the content of glucose is lower, Illustrate that HGT1 albumen promotes the absorption of glucose, and the enhancing of glucose absorption can increase lemon acid yield.
Fig. 2 is the citric acid of above two bacterial strain than rate of producing acid test result, it can be seen that recombinant bacterial strain of the invention Citric acid output speed it is higher, reason is that the overexpression of HGT1 albumen enhances the transhipment of glucose, can carry high acid Speed, illustrates that glucose absorption is to improve the Steps of lemon acid yield.Compared with wild type Aspergillus niger bacterial strain, the present invention Recombinant aspergillus niger bacterial strain fermentation time reduction 6h.
The above is only the preferred embodiment of the present invention, is not intended to limit the invention, it is noted that for this skill For the those of ordinary skill in art field, on the premise of the technology of the present invention principle is not departed from, can also make it is some improvement and Modification, these are improved and modification also should be regarded as protection scope of the present invention.
Sequence table
<110>Southern Yangtze University
<120>The construction method of the restructuring mould of citric acid output increased and application
<160> 13
<170> PatentIn version 3.3
<210> 1
<211> 1644
<212> DNA
<213>HGT1 genes
<400> 1
1 ATGTTGATTG GCAACATCTA CGTGATTGCG AGCGTCGCCG TCGTCGGCGG CGGCTTGTTT
61 GGCTTTGATA TTTCCTCCAT GTCCGCTCAG CTGAGCGAGA ATTCCTATCT ATGCTATTTC
121 AACCAGGGCC CTAAGGGTCC TCCCTTCACT GACGATGAGG ACTGTTCTGG TCCCACATCC
181 CTCAACCAGG GTGGCATCAC GGCAGCCATG GCAGCTGGAT CTTGGCTGGG TGCTTTGATT
241 TCAGGTCCGC TTTCCGATCG CATCGGACGT AAGACGTCCA TCATGGTCGG CTGTGTCGTT
301 TGGCTGATTG GTTCCACCAT TATGTGCGCT TCTCAGAACA TCGGTATGCT CGTTGTTGGG
361 CGGGTCATCA ACGGTCTCGC GGTGGGCATT GAGTCTGCTC AGGTCCCCGT CTACATCAGT
421 GAACTTTCGC CACCCTCCAA GCGCGGTCGG TTCGTAGGTA TGCAGCAATG GGCCATTACA
481 TGGGGTATCC TCATTATGTT CTATATCTCG TATGGCTGCT CCTTCATCGG GGGACAGAAG
541 TCCTACAACT ACAGCACTGC TTCTTGGCGA GTCCCCTGGG GCTTGCAGAT GCTGCCGGCT
601 GTTTTCCTTT TCCTTGGAAT GCTGGTTCTG CCCGAATCTC CTCGTTGGCT GGCGCGCAAG
661 GATCGTTGGG AGGACTGCCA TCGGGTCTTG GCTCTCGTCC ACGCCAAGGG GGATCTCAAC
721 CATCCTTTCG TTGCGCTAGA GTTGCAGGAC ATTCGGGATA TGTGTGAGCT TGAACGTCAG
781 TTCAAAGATG TCACTTACCT TGACCTGTTC AAACCGAGGA TGATCAACCG CACGTTGATC
841 GGTCTGTTCA TGCAGATCTG GTCTCAGCTG ACCGGCATGA ATGTGATGAT GTACTACATC
901 ACGTATCTCT TTTCTATGGC TGGATACACC GGCGATTCCA CCCTCCTTGC CTCCTCCATT
961 CAGTATATTA TCAATGTGTT TATGACCCTC CCGGCACTGA TCTGGATGGA CAAGTGGGGT
1021 CGTCGCATGC CATTGCTGGT TGGCGCAGCT CTGATGGCCA TCTTGATGTA TGCCAATGGT
1081 GCGATCATGG CGGTTCATGG TGTTGTGGTG CCCGGGGGCA TCAATGGGGT TGCAGCTGAG
1141 TCCATGCGTC TTCACGGCGC TCCTGCCAAA GGTTTGATTG CTTGCACATA CCTCTTCGTC
1201 GCGTCGTATG CGCCTACCTG GGGTCCTGTA TCCTGGACGT ACCCCCCTGA GCTGTATCCG
1261 CTGCGGCTGC GTGGTAAGGG AGTGGCTTTG TCGACCTCAG GTAACTGGGC GTTTAACACT
1321 GCATTGGGGC TGTTTACACC CACTGCATTT GAGAACATCC GCTGGAAGAC CTACATCATG
1381 TTTGGGGTGT TCAACACTGC CATGTTCTTG CACGTGCTGT TCCTGTTCCC GGAGACTGCA
1441 GGAAAGACGC TCGAAGAGAC CGAAGCCATG TTCGAGGATC CCAACGGCAT CAAGTACATT
1501 GGCACACCGG CCTGGAAGAC CAAGATGAAG ACCCGGCAGG TGGAGCAGCT GGAGCACGGT
1561 CAAGTGGATA TAGAGTCCAA GATTGAAACC CGCCACGCAG AGACCACTGA GACCGCTCCC
1621 AAATCCCAGG AGGCCACAGC ATAA
<210> 2
<211> 547
<212>Amino acid
<213>The amino acid of HGT1 protein coding genes coding
<400> 2
Met Leu Ile Gly Asn Ile Tyr Val Ile Ala Ser Val Ala Val Val
1 5 10 15
Gly Gly Gly Leu Phe Gly Phe Asp Ile Ser Ser Met Ser Ala Gln
20 25 30
Leu Ser Glu Asn Ser Tyr Leu Cys Tyr Phe Asn Gln Gly Pro Lys
35 40 45
Gly Pro Pro Phe Thr Asp Asp Glu Asp Cys Ser Gly Pro Thr Ser
50 55 60
Leu Asn Gln Gly Gly Ile Thr Ala Ala Met Ala Ala Gly Ser Trp
65 70 75
Leu Gly Ala Leu Ile Ser Gly Pro Leu Ser Asp Arg Ile Gly Arg
80 85 90
Lys Thr Ser Ile Met Val Gly Cys Val Val Trp Leu Ile Gly Ser
95 100 105
Thr Ile Met Cys Ala Ser Gln Asn Ile Gly Met Leu Val Val Gly
110 115 120
Arg Val Ile Asn Gly Leu Ala Val Gly Ile Glu Ser Ala Gln Val
125 130 135
Pro Val Tyr Ile Ser Glu Leu Ser Pro Pro Ser Lys Arg Gly Arg
140 145 150
Phe Val Gly Met Gln Gln Trp Ala Ile Thr Trp Gly Ile Leu Ile
155 160 165
Met Phe Tyr Ile Ser Tyr Gly Cys Ser Phe Ile Gly Gly Gln Lys
170 175 180
Ser Tyr Asn Tyr Ser Thr Ala Ser Trp Arg Val Pro Trp Gly Leu
185 190 195
Gln Met Leu Pro Ala Val Phe Leu Phe Leu Gly Met Leu Val Leu
200 205 210
Pro Glu Ser Pro Arg Trp Leu Ala Arg Lys Asp Arg Trp Glu Asp
215 220 225
Cys His Arg Val Leu Ala Leu Val His Ala Lys Gly Asp Leu Asn
230 235 240
His Pro Phe Val Ala Leu Glu Leu Gln Asp Ile Arg Asp Met Cys
245 250 255
Glu Leu Glu Arg Gln Phe Lys Asp Val Thr Tyr Leu Asp Leu Phe
260 265 270
Lys Pro Arg Met Ile Asn Arg Thr Leu Ile Gly Leu Phe Met Gln
275 280 285
Ile Trp Ser Gln Leu Thr Gly Met Asn Val Met Met Tyr Tyr Ile
290 295 300
Thr Tyr Leu Phe Ser Met Ala Gly Tyr Thr Gly Asp Ser Thr Leu
305 310 315
Leu Ala Ser Ser Ile Gln Tyr Ile Ile Asn Val Phe Met Thr Leu
320 325 330
Pro Ala Leu Ile Trp Met Asp Lys Trp Gly Arg Arg Met Pro Leu
335 340 345
Leu Val Gly Ala Ala Leu Met Ala Ile Leu Met Tyr Ala Asn Gly
350 355 360
Ala Ile Met Ala Val His Gly Val Val Val Pro Gly Gly Ile Asn
365 370 375
Gly Val Ala Ala Glu Ser Met Arg Leu His Gly Ala Pro Ala Lys
380 385 390
Gly Leu Ile Ala Cys Thr Tyr Leu Phe Val Ala Ser Tyr Ala Pro
395 400 405
Thr Trp Gly Pro Val Ser Trp Thr Tyr Pro Pro Glu Leu Tyr Pro
410 415 420
Leu Arg Leu Arg Gly Lys Gly Val Ala Leu Ser Thr Ser Gly Asn
425 430 435
Trp Ala Phe Asn Thr Ala Leu Gly Leu Phe Thr Pro Thr Ala Phe
450 440 445 450
Glu Asn Ile Arg Trp Lys Thr Tyr Ile Met Phe Gly Val Phe Asn
455 460 465
Thr Ala Met Phe Leu His Val Leu Phe Leu Phe Pro Glu Thr Ala
470 475 480
Gly Lys Thr Leu Glu Glu Thr Glu Ala Met Phe Glu Asp Pro Asn
485 490 495
Gly Ile Lys Tyr Ile Gly Thr Pro Ala Trp Lys Thr Lys Met Lys
500 505 510
Thr Arg Gln Val Glu Gln Leu Glu His Gly Gln Val Asp Ile Glu
515 520 525
Ser Lys Ile Glu Thr Arg His Ala Glu Thr Thr Glu Thr Ala Pro
530 535 540
Lys Ser Gln Glu Ala Thr Ala
545
<210> 3
<211> 2310
<212> DNA
<213>PgpdA promoters
<400> 3
1 CAATTCCCTT GTATCTCTAC ACACAGGCTC AAATCAATAA GAAGAACGGT TCGTCTTTTT
61 CGTTTATATC TTGCATCGTC CCAAAGCTAT TGGCGGGATA TTCTGTTTGC AGTTGGCTGA
121 CTTGAAGTAA TCTCTGCAGA TCTTTCGACA CTGAAATACG TCGAGCCTGC TCCGCTTGGA
181 AGCGGCGAGG AGCCTCGTCC TGTCACAACT ACCAACATGG AGTACGATAA GGGCCAGTTC
241 CGCCAGCTCA TTAAGAGCCA GTTCATGGGC GTTGGCATGA TGGCCGTCAT GCATCTGTAC
301 TTCAAGTACA CCAACCCTCT TCTGATCCAG TCGATCATCC CGCTGAAGGG CGCTTTCGAA
361 TCGAATCTGG TTAAGATCCA CGTCTTCGGG AAGCCAGCGA CTGGTGACCT CCAGCGTCCC
421 TTTAAGGCTG CCAACAGCTT TCTCAGCCAG GGCCAGCCCA AGACCGACAA GGCCTCCCTC
481 CAGAACGCCG AGAAGAACTG GAGGGGTGGT GTCAAGGAGG AGTAAGCTCC TTATTGAAGT
541 CGGAGGACGG AGCGGTGTCA AGAGGATATT CTTCGCTCTG TATTATAGAT AAGATGATGA
601 GGAATTGGAG GTAGCATAGC TTCATTTGGA TTTGCTTTCC AGGCTGAGAC TCTAGCTTGG
661 AGCATAGAGG GTCCCTTTGG CTTTCAATAT TCTCAAGTAT CTCGAGTTTG AACTTATTCC
721 CGTGAACCTT TTATTCACCA ATGAGCATTG GAATGAACAT GAATCTGAGG ACTGCAATCG
781 CCATGAGGTT TTCGAAATAC ATCCGGATGT CGAAGGCTTG GGGCACCTGC GTTGGTTGAA
841 TTTAGAACGT GGCACTATTG ATCATCCGAT AGCTCTGCAA AGGGCGTTGC ACAATGCAAG
901 TCAAACGTTG CTAGCAGTTC CAGGTGGAAT GTTATGATGA GCATTGTATT AAATCAGGAG
961 ATATAGCATG ATCTCTAGTT AGCTCACCAC AAAAGTCAGA CGGCGTAACC AAAAGTCACA
1021 CAACACAAGC TGTAAGGATT TCGGCACGGC TACGGAAGAC GGAGAAGCCC ACCTTCAGTG
1081 GACTCGAGTA CCATTTAATT CTATTTGTGT TTGATCGAGA CCTAATACAG CCCCTACAAC
1141 GACCATCAAA GTCGTATAGC TACCAGTGAG GAAGTGGACT CAAATCGACT TCAGCAACAT
1201 CTCCTGGATA AACTTTAAGC CTAAACTATA CAGAATAAGA TGGTGGAGAG CTTATACCGA
1261 GCTCCCAAAT CTGTCCAGAT CATGGTTGAC CGGTGCCTGG ATCTTCCTAT AGAATCATCC
1321 TTATTCGTTG ACCTAGCTGA TTCTGGAGTG ACCCAGAGGG TCATGACTTG AGCCTAAAAT
1381 CCGCCGCCTC CACCATTTGT AGAAAAATGT GACGAACTCG TGAGCTCTGT ACAGTGACCG
1441 GTGACTCTTT CTGGCATGCG GAGAGACGGA CGGACGCAGA GAGAAGGGCT GAGTAATAAG
1501 CGCCACTGCG CCAGACAGCT CTGGCGGCTC TGAGGTGCAG TGGATGATTA TTAATCCGGG
1561 ACCGGCCGCC CCTCCGCCCC GAAGTGGAAA GGCTGGTGTG CCCCTCGTTG ACCAAGAATC
1621 TATTGCATCA TCGGAGAATA TGGAGCTTCA TCGAATCACC GGCAGTAAGC GAAGGAGAAT
1681 GTGAAGCCAG GGGTGTATAG CCGTCGGCGA AATAGCATGC CATTAACCTA GGTACAGAAG
1741 TCCAATTGCT TCCGATCTGG TAAAAGATTC ACGAGATAGT ACCTTCTCCG AAGTAGGTAG
1801 AGCGAGTACC CGGCGCGTAA GCTCCCTAAT TGGCCCATCC GGCATCTGTA GGGCGTCCAA
1861 ATATCGTGCC TCTCCTGCTT TGCCCGGTGT ATGAAACCGG AAAGGCCGCT CAGGAGCTGG
1921 CCAGCGGCGC AGACCGGGAA CACAAGCTGG CAGTCGACCC ATCCGGTGCT CTGCACTCGA
1981 CCTGCTGAGG TCCCTCAGTC CCTGGTAGGC AGCTTTGCCC CGTCTGTCCG CCCGGTGTGT
2041 CGGCGGGGTT GACAAGGTCG TTGCGTCAGT CCAACATTTG TTGCCATATT TTCCTGCTCT
2101 CCCCACCAGC TGCTCTTTTC TTTTCTCTTT CTTTTCCCAT CTTCAGTATA TTCATCTTCC
2161 CATCCAAGAA CCTTTATTTC CCCTAAGTAA GTACTTTGCT ACATCCATAC TCCATCCTTC
2221 CCATCCCTTA TTCCTTTGAA CCTTTCAGTT CGAGCTTTCC CACTTCATCG CAGCTTGACT
2281 AACAGCTACC CCGCTTGAGC AGACATCACC
<210> 4
<211> 771
<212> DNA
<213>Trp terminators
<400> 4
1 GATCCACTTA ACGTTACTGA AATCATCAAA CAGCTTGACG AATCTGGATA TAAGATCGTT
61 GGTGTCGATG TCAGCTCCGG AGTTGAGACA AATGGTGTTC AGGATCTCGA TAAGATACGT
121 TCATTTGTCC AAGCAGCAAA GAGTGCCTTC TAGTGATTTA ATAGCTCCAT GTCAACAAGA
181 ATAAAACGCG TTTCGGGTTT ACCTCTTCCA GATACAGCTC ATCTGCAATG CATTAATGCA
241 TTGGACCTCG CAACCCTAGT ACGCCCTTCA GGCTCCGGCG AAGCAGAAGA ATAGCTTAGC
301 AGAGTCTATT TTCATTTTCG GGAGACGAGA TCAAGCAGAT CAACGGTCGT CAAGAGACCT
361 ACGAGACTGA GGAATCCGCT CTTGGCTCCA CGCGACTATA TATTTGTCTC TAATTGTACT
421 TTGACATGCT CCTCTTCTTT ACTCTGATAG CTTGACTATG AAAATTCCGT CACCAGCCCC
481 TGGGTTCGCA AAGATAATTG CACTGTTTCT TCCTTGAACT CTCAAGCCTA CAGGACACAC
541 ATTCATCGTA GGTATAAACC TCGAAAATCA TTCCTACTAA GATGGGTATA CAATAGTAAC
601 CATGGTTGCC TAGTGAATGC TCCGTAACAC CCAATACGCC GGCCGAAACT TTTTTACAAC
661 TCTCCTATGA GTCGTTTACC CAGAATGCAC AGGTACACTT GTTTAGAGGT AATCCTTCTT
721 TCTAGAAGTC CTCGTGTACT GTGTAAGCGC CCACTCCACA TCTCCACTCG A
<210> 5
<211> 1020
<212> DNA
<213>Hph terminators
<400> 5
1 ATGCCTGAAC TCACCGCGAC GTCTGTCGAG AAGTTTCTGA TCGAAAAGTT CGACAGCGTC
61 TCCGACCTGA TGCAGCTCTC GGAGGGCGAA GAATCTCGTG CTTTCAGCTT CGATGTAGGA
121 GGGCGTGGAT ATGTCCTGCG GGTAAATAGC TGCGCCGATG GTTTCTACAA AGATCGTTAT
181 GTTTATCGGC ACTTTGCATC GGCCGCGCTC CCGATTCCGG AAGTGCTTGA CATTGGGGAA
241 TTCAGCGAGA GCCTGACCTA TTGCATCTCC CGCCGTGCAC AGGGTGTCAC GTTGCAAGAC
301 CTGCCTGAAA CCGAACTGCC CGCTGTTCTG CAGCCGGTCG CGGAGGCCAT GGATGCGATC
361 GCTGCGGCCG ATCTTAGCCA GACGAGCGGG TTCGGCCCAT TCGGACCGCA AGGAATCGGT
421 CAATACACTA CATGGCGTGA TTTCATATGC GCGATTGCTG ATCCCCATGT GTATCACTGG
481 CAAACTGTGA TGGACGACAC CGTCAGTGCG TCCGTCGCGC AGGCTCTCGA TGAGCTGATG
541 CTTTGGGCCG AGGACTGCCC CGAAGTCCGG CACCTCGTGC ACGCGGATTT CGGCTCCAAC
601 AATGTCCTGA CGGACAATGG CCGCATAACA GCGGTCATTG ACTGGAGCGA GGCGATGTTC
661 GGGGATTCCC AATACGAGGT CGCCAACATC TTCTTCTGGA GGCCGTGGTT GGCTTGTATG
721 GAGCAGCAGA CGCGCTACTT CGAGCGGAGG CATCCGGAGC TTGCAGGATC GCCGCGGCTC
781 CGGGCGTATA TGCTCCGCAT TGGTCTTGAC CAACTCTATC AGAGCTTGGT TGACGGCAAT
841 TTCGATGATG CAGCTTGGGC GCAGGGTCGA TGCGACGCAA TCGTCCGATC CGGAGCCGGG
901 ACTGTCGGGC GTACACAAAT CGCCCGCAGA AGCGCGGCCG TCTGGACCGA TGGCTGTGTA
961 GAAGTACTCG CCGATAGTGG AAACCGACGC CCCAGCACTC GTCCGAGGGC AAAGGAATAG
<210> 6
<211> 31
<212> DNA
<213>Primer trp-F
<400> 6
1 ctgcaggatc cacttaaacg ttactgaaat c
<210> 7
<211> 28
<212> DNA
<213>Primer trp-R
<400> 7
1 AAGCTTCTCG AGTGGAGATG TGGAGTGG
<210> 8
<211> 40
<212> DNA
<213>Primer Pgpd-F
<400> 8
1 GAATTCGCGG CCGCCAATTC CCTTGTATCT CTACACACAG
<210> 9
<211> 26
<212> DNA
<213>Primer Pgpd-R
<400> 9
1 GGTACCGGTG ATGTCTGCTC AAGCGG
<210> 10
<211> 45
<212> DNA
<213>Primer HGT1-F
<400> 10
1 CTTGAGCAGA CATCACCGGT ACCATGTTGA TTGGCAACAT CTACG
<210> 11
<211> 44
<212> DNA
<213>Primer HGT1-R
<400> 11
1 TAACGTTTAA GTGGATCGGA TCCTTATGCT GTGGCCTCCT GGGA
<210> 12
<211> 26
<212> DNA
<213>Primer gpd-F
<400> 12
1 CAATTCCCTT GTATCTCTAC ACACAG
<210> 13
<211> 22
<212> DNA
<213>Primer Ttrp-R-2
<400> 13
1 CTCGAGTGGA GATGTGGAGT GG

Claims (12)

1. a kind of citric acid output increased restructuring mould construction method, it is characterised in that comprise the following steps:
(1) HGT1 protein expression frames are built, the HGT1 protein expressions frame starts comprising constitutive promoter and the composing type The HGT1 protein coding genes of son connection and the terminator being connected with the HGT1 protein coding genes;
(2) tolerant gene expression frame is built, the tolerant gene expression frame starts comprising constitutive promoter and the composing type The hph genes of son connection and the terminator being connected with the hph genes;
(3) the tolerant gene expression frame that step (1) the HGT1 protein expressions frame and step (2) are obtained is transformed into mould In, obtain the restructuring mould.
2. citric acid output increased according to claim 1 restructuring mould construction method, it is characterised in that:In step (1) in, the HGT1 protein coding genes derive from aspergillus niger.
3. citric acid output increased according to claim 2 restructuring mould construction method, it is characterised in that:In step (1) in, the nucleotide sequence of the HGT1 protein coding genes is as shown in SEQ ID NO.1.
4. citric acid output increased according to claim 1 restructuring mould construction method, it is characterised in that:In step (1) in neutralization procedure (2), the constitutive promoter is opened for PgpdA promoters, gpdA promoters, Pmbf promoters or Pgla Mover.
5. citric acid output increased according to claim 1 restructuring mould construction method, it is characterised in that:In step (1) and in step (2), the terminator is trp terminators.
6. citric acid output increased according to claim 1 restructuring mould construction method, it is characterised in that:In step (3) in, the mould is aspergillus niger, aspergillus oryzae or aspergillus nidulans.
7. a kind of HGT1 protein expressions frame, including constitutive promoter and the HGT1 albumen of constitutive promoter connection are compiled Code gene and the terminator being connected with the HGT1 protein coding genes.
8. HGT1 protein expressions frame according to claim 7, it is characterised in that:The constitutive promoter is opened for PgpdA Mover, gpdA promoters, Pmbf promoters or Pgla promoters.
9. HGT1 protein expressions frame according to claim 7, it is characterised in that:The HGT1 protein coding genes are derived from Aspergillus niger, the nucleotide sequence of the HGT1 protein coding genes is as shown in SEQ ID NO.1.
10. HGT1 protein expressions frame according to claim 7, it is characterised in that:The terminator is trp terminators.
A kind of 11. restructuring moulds built by any one of claim 1-6 method.
12. applications of the restructuring mould in fermentation production of citric acid built according to any one of claim 1-6 method.
CN201611236665.8A 2016-12-28 2016-12-28 Construction method and application of recombinant mold with increased citric acid yield Active CN106754435B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611236665.8A CN106754435B (en) 2016-12-28 2016-12-28 Construction method and application of recombinant mold with increased citric acid yield

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611236665.8A CN106754435B (en) 2016-12-28 2016-12-28 Construction method and application of recombinant mold with increased citric acid yield

Publications (2)

Publication Number Publication Date
CN106754435A true CN106754435A (en) 2017-05-31
CN106754435B CN106754435B (en) 2020-04-21

Family

ID=58924941

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611236665.8A Active CN106754435B (en) 2016-12-28 2016-12-28 Construction method and application of recombinant mold with increased citric acid yield

Country Status (1)

Country Link
CN (1) CN106754435B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108018216A (en) * 2017-12-26 2018-05-11 天津科技大学 Improve the method and application of sugar utilization and lemon acid yield in citric acid fermentation
CN112250740A (en) * 2020-10-21 2021-01-22 中国科学院天津工业生物技术研究所 Glucose transport protein and application thereof in improving production of organic acid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014202624A2 (en) * 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Rasamsonia gene and use thereof
CN107236757A (en) * 2016-03-28 2017-10-10 中国科学院天津工业生物技术研究所 A kind of method for improving the expression of filamentous fungi lignocellulosic enzyme system and biological-based chemicals production

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014202624A2 (en) * 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Rasamsonia gene and use thereof
CN107236757A (en) * 2016-03-28 2017-10-10 中国科学院天津工业生物技术研究所 A kind of method for improving the expression of filamentous fungi lignocellulosic enzyme system and biological-based chemicals production

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JOSEP V. FORMENT: "High-Affinity Glucose Transport in Aspergillus nidulans Is Mediated by the Products of Two Related but Differentially Expressed Genes", 《PLOS ONE》 *
N. V. TORRES: "Glucose transport by Aspergillus niger: the low.affinity carrier is only formed during growth on high glucose concentrations", 《APPL MICROBIOL BIOTECHNOL》 *
XIE X等: "Transcriptional response to glucose starvation and functional analysis of a glucose transporter of Neurospora crassa", 《FUNGAL GENET BIOL.》 *
林良才: "粗糙脉孢菌木质纤维素降解利用研究进展", 《生物加工过程》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108018216A (en) * 2017-12-26 2018-05-11 天津科技大学 Improve the method and application of sugar utilization and lemon acid yield in citric acid fermentation
CN108018216B (en) * 2017-12-26 2021-06-18 天津科技大学 Method for improving sugar utilization rate and citric acid yield in citric acid fermentation and application
CN112250740A (en) * 2020-10-21 2021-01-22 中国科学院天津工业生物技术研究所 Glucose transport protein and application thereof in improving production of organic acid
CN112250740B (en) * 2020-10-21 2021-11-23 中国科学院天津工业生物技术研究所 Glucose transport protein and application thereof in improving production of organic acid

Also Published As

Publication number Publication date
CN106754435B (en) 2020-04-21

Similar Documents

Publication Publication Date Title
CN106755138A (en) It is a kind of to improve the method that fermentation of Aspergillus niger produces lemon acid yield
CN105886408B (en) The screening and its application of ocean schizophyllum commune bacterial strain
CN107574159A (en) A kind of mutant for the glutamine transaminage expressed in an active
CN102839165A (en) Gene mutation type recombined protease K and industrialized production method thereof
CN102618552B (en) Productive technology of recombined exenatide
CN104263710A (en) Beta-galactosidase combined mutant with high transglycosylation activity as well as preparation method and application of beta-galactosidase combined mutant
CN105018448B (en) The heat-resisting acidic cellulase and its gene of a kind of originated from fungus and application
CN103881994A (en) Beta-galactosidase mutant with high transglycosylation activity and preparation method and application thereof
CN112725319B (en) Alginate lyase FaAly7 with polyG substrate specificity and application thereof
CN106754435A (en) The construction method of the restructuring mould of citric acid output increased and application
CN103981112A (en) Double-promoter multi-copy recombinant pichia pastoris strain for highly producing endo-inulinase
CN105695340A (en) Aspergillus oryzae and application thereof
CN104404064A (en) Tyrosinase coding gene melC derived from streptomyces kathirae SC-1 and proteins of tyrosinase coding genes melC
CN106929496A (en) A kind of pharmaceutical grade recombined human kininogenase industrialization production method
CN106635847A (en) Recombinant aspergillus niger capable of improving yield of citric acid and preparation method of recombinant aspergillus niger
CN101469325A (en) Secretory expression method for exoinulinase from Kluyveromyces marxianus
CN105200078A (en) Aspergillus niger gene knockout method
CN104726388B (en) A kind of Pullulanase bacterium producing multi enzyme preparation and the method for improving its enzymatic productivity
CN105154417B (en) The acidic cellulase and its gene of a kind of originated from fungus and application
CN108018216A (en) Improve the method and application of sugar utilization and lemon acid yield in citric acid fermentation
CN105154420B (en) Red sesame Terpene synthase GL22395 encoding genes cDNA sequence and its application
CN103897993A (en) Saccharomyces cerevisiae gene engineering strain, construction method of same and method for producing eriodictyol or quercetin
CN111304235A (en) Bacillus licheniformis for enhancing expression of cysP and preparation method and application thereof
CN110343624B (en) Recombinant strain and application thereof in improving yield of cellulase
CN105936896A (en) Preparation and applications of polyclonal antibody of bactericidal enoyl reductase

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant